Syngene Financial Statements

Syngene (SYNGENE) reported revenue of ₹37.14B in FY2025 with net income of ₹4.96B. Total assets stood at ₹67.96B and free cash flow was ₹4.07B.

Syngene Income Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Revenue		35.79B	37.14B
Cost of Rev. Cost of Revenue		-9.30B	-9.43B
Gross Profit		26.49B	27.72B
SGA Sales, General & Admin		-15.44B	-16.58B
Op. Income Operating Income		6.79B	6.81B
PBT Profit Before Tax		6.21B	6.60B
Net Income		5.10B	4.96B
Dil. Shares Diluted Shares		401.97M	402.32M
Diluted EPS		12.69	12.34

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Syngene's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Syngene Balance Sheet

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Curr. assets Total current assets		19.59B	22.87B
Non-curr. assets Total non-current assets		41.93B	45.09B
Total assets		61.52B	67.96B
Curr. liabilities Total current liabilities		11.44B	13.96B
Non-curr. liab. Total non-current liabilities		7.50B	6.73B
Total liabilities		18.94B	20.69B
Total equity		42.58B	47.27B
Total liab. & eq. Total liabilities & equity		61.52B	67.96B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Syngene's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Syngene Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025

Item	Chart	2024	2025
Net Income		5.10B	4.96B
Operating CF Cash flow Operating Activities		10.42B	11.68B
Capex Investments in PPE		-4.92B	-7.60B
Investing CF Cash flow Investing Activities		-4.96B	-7.45B
Dividend Paid		-503.00M	-503.00M
Financing CF Cash flow Financing Activities		-5.51B	-1.42B
Cash (start) Cash at beginning of period		895.00M	857.00M
Cash (end) Cash at end of period		857.00M	3.67B
FCF Free Cash Flow		5.50B	4.07B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Syngene's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025